Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Australas J Dermatol ; 62(3): e411-e413, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34170516

ABSTRACT

Purpureocillium lilacinum, previously classified as Paecilomyces lilacinus, is a ubiquitous hyaline hyphomycete considered to be an emerging opportunistic human pathogen that is resistant to traditional antifungal agents. This case report describes what is to our knowledge the only published case of P. lilacinum recrudescence in an immunocompetent host despite initial best-practice treatment with 10 weeks of voriconazole and surgical excision.


Subject(s)
Antifungal Agents/therapeutic use , Dermatomycoses/drug therapy , Hyalohyphomycosis/drug therapy , Hypocreales/isolation & purification , Dermatomycoses/microbiology , Humans , Hyalohyphomycosis/microbiology , Recurrence
SELECTION OF CITATIONS
SEARCH DETAIL
...